Gordana Vlahovic Selected Research

Gordana Vlahovic Research Topics

Disease

19	Neoplasms (Cancer) 05/2019 - 01/2003
5	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2014
4	Glioma (Gliomas) 12/2018 - 01/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2003
3	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2017
3	Hypoxia (Hypoxemia) 11/2013 - 02/2008
2	Adenocarcinoma 10/2019 - 12/2009
2	Fatigue 09/2017 - 06/2015
2	Thrombocytopenia (Thrombopenia) 06/2015 - 07/2012
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018
1	Inflammation (Inflammations) 12/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Chronic Disease (Chronic Diseases) 09/2017
1	Neoplasm Metastasis (Metastasis) 07/2016
1	Lymphoma (Lymphomas) 06/2015
1	Multiple Myeloma 06/2015
1	Hematologic Neoplasms (Hematological Malignancy) 06/2015
1	Exanthema (Rash) 07/2012
1	Mucositis 07/2012
1	Anemia 05/2012
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 11/2011
1	Adenocarcinoma of Lung 12/2009
1	Carcinoma (Carcinomatosis) 05/2007
1	Rectal Neoplasms (Rectal Cancer) 05/2007
1	Philadelphia Chromosome 01/2003
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2003
1	Leukemia 01/2003

Drug/Important Bio-Agent (IBA)

5	Bevacizumab (Avastin)FDA Link 01/2018 - 05/2007
4	VaccinesIBA 01/2018 - 03/2016
4	Pharmaceutical PreparationsIBA 01/2018 - 01/2003
2	durvalumabIBA 10/2019 - 05/2019
2	Everolimus FDA Link 01/2018 - 07/2012
2	Panitumumab (Vectibix)FDA Link 01/2018 - 07/2012
1	tremelimumabIBA 10/2019
1	GlucocorticoidsIBA 12/2018
1	poliovirus receptorIBA 12/2018
1	IpilimumabIBA 01/2018
1	AntigensIBA 01/2018
1	ganitumabIBA 01/2018
1	rilotumumabIBA 01/2018
1	NivolumabIBA 01/2018
1	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 09/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Lysosomal Membrane ProteinsIBA 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	Protein Subunit VaccinesIBA 01/2017
1	Angiopoietin-1IBA 09/2016
1	TIE-2 Receptor (Receptor, TIE 2)IBA 09/2016
1	B7-H1 AntigenIBA 08/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2015
1	Proteasome InhibitorsIBA 06/2015
1	ixazomibIBA 06/2015
1	Carboplatin (JM8)FDA LinkGeneric 10/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2014
1	navitoclaxIBA 10/2014
1	Proteins (Proteins, Gene)FDA Link 10/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	Peptides (Polypeptides)IBA 01/2014
1	IsotopesIBA 11/2013
1	Epidermal Growth Factor (EGF)IBA 11/2013
1	Dihydrotachysterol (AT 10)IBA 07/2012
1	IronIBA 05/2012
1	HematinicsIBA 05/2012
1	Neuronal Apoptosis-Inhibitory ProteinIBA 11/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2011
1	Biological ProductsIBA 12/2009
1	Cisplatin (Platino)FDA LinkGeneric 12/2009
1	Monoclonal AntibodiesIBA 07/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2008
1	Biomarkers (Surrogate Marker)IBA 07/2008
1	copper pyruvaldehyde bis(N(4)-methylthiosemicarbazone) complexIBA 02/2008
1	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 02/2008
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2008
1	SurvivinIBA 05/2007
1	Fluorouracil (Carac)FDA LinkGeneric 05/2007
1	EnzymesIBA 01/2003
1	Docetaxel (Taxotere)FDA Link 01/2003
1	Tyrosine (L-Tyrosine)FDA Link 01/2003
1	Imatinib Mesylate (Gleevec)FDA Link 01/2003
1	PlatinumIBA 01/2003
1	Phosphotransferases (Kinase)IBA 01/2003
1	ErbB Receptors (EGF Receptor)IBA 01/2003
1	Gefitinib (Iressa)FDA Link 01/2003

Therapy/Procedure

5	Immunotherapy 01/2018 - 08/2015
5	Drug Therapy (Chemotherapy) 01/2017 - 01/2003
3	Therapeutics 12/2018 - 02/2008
1	Catheters 12/2018
1	Oncolytic Virotherapy 03/2016
1	Radiotherapy 03/2016